NCT03617016View on ClinicalTrials.gov

Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

August 27, 2018

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Dyspepsia
Interventions
DRUG

Domperidone

Participants will receive domperidone tablets orally.

DRUG

Placebo

Participants will receive matching placebo to domperidone tablets orally.

Trial Locations (5)

100050

Capital Medical University, Beijing Friendship Hospital, Beijing

100730

Peking Union Medical College Hospital, Beijing

350001

Fujian Provincial Hospital, Fuzhou

430022

Union Hospital Tongji Medical College of Huazhong University of Science and Technology, Wuhan

430030

Tongji Hospital, Tongji Medical College of HUST, Wuhan

All Listed Sponsors
lead

Xian-Janssen Pharmaceutical Ltd.

INDUSTRY

NCT03617016 - Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia | Biotech Hunter | Biotech Hunter